Alex Berenson Returns to Twitter After 'Mutually Acceptable Resolution' to Lawsuit Over COVID Posts

Patrick Taylor | July 8, 2022
Text Audio
00:00 00:00
Font Size

Alex Berenson, a journalist and author who has publicly questioned the safety and efficacy of COVID-19 vaccines, has returned to Twitter after the settlement of his lawsuit against the social media giant.

A Twitter spokesperson said of the settlement, "The parties have come to a mutually acceptable resolution. Twitter has reinstated Mr. Berenson. Upon further review, Twitter acknowledges Mr. Berenson’s Tweets should not have led to his suspension at that time.”

According to Berenson, his reinstatement was related to the fact that Twitter had “begun the process of modifying its terms of service when it set up its five-strike Covid misinformation policy.”

He explained, “[O]nce the company voluntarily sets guidelines that it says it will follow in disciplining or banning users, IT MUST FOLLOW THOSE.”

Berenson emphasized, “Now here's the key: In settling the case, acknowledging error, and reinstating me, Twitter has inherently - and publicly - accepted this theory of its contractual obligations.”

This theory, Berenson believes, will benefit free speech across the platform, aside from the particularities of his case (which also involved a Twitter executive's emails with Berenson).

Related: Evil People: Lefty Harassment Forces Kavanaugh to Leave Restaurant By Back

In a show of triumph following his reinstatement, Berenson reposted the tweet that initially led to his suspension, writing, "It doesn’t stop infection. Or transmission. Don’t think of it as a vaccine. Think of it - at best - as a therapeutic with a limited window of efficacy and terrible side effect profile that must be dosed IN ADVANCE OF ILLNESS. And we want to mandate it? Insanity."

The “investigation into the pressures that the government may have placed on Twitter to suspend [his] account,” Berenson said, still continues. And Elon Musk, who may soon be the owner of the Big Tech firm, is interested.

Follow us on Twitter!